Dementia with Lewy bodies (DLB) is a complex form of dementia that shares similarities with both Alzheimer's disease and Parkinson's disease. It is characterized by the accumulation of abnormal protein deposits in the brain called Lewy bodies, which can lead to a progressive decline in cognitive abilities, motor functions, and changes in behavior. DLB often presents with fluctuating cognitive symptoms, visual hallucinations, sleep disturbances, and Parkinsonism (such as tremors and rigidity). Unlike Alzheimer's, where memory loss is usually prominent early on, DLB typically involves more pronounced attention and visual-spatial impairments in its early stages. Managing DLB requires a comprehensive approach involving medication management, support for cognitive and motor symptoms, and support for caregivers due to the complex and fluctuating nature of the disease.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States